Rafferty Asset Management
ABMD

Rafferty Asset Management’s Abiomed Inc ABMD Stock Holding History

Rafferty Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,406
Closed -$1.08M – 1172
2022
Q3 		$1.08M Buy
4,406
+1,560
+55% +$421K 0.01% 653
2022
Q2 		$704K Buy
2,846
+1,454
+104% +$392K 0.01% 740
2022
Q1 		$461K Sell
1,392
-137
-9% -$42.2K ﹤0.01% 1028
2021
Q4 		$549K Buy
1,529
+82
+6% +$27.7K ﹤0.01% 1046
2021
Q3 		$471K Buy
1,447
+509
+54% +$172K ﹤0.01% 1056
2021
Q2 		$293K Buy
938
+38
+4% +$11.7K ﹤0.01% 1181
2021
Q1 		$287K Buy
900
+81
+10% +$25.9K ﹤0.01% 1091
2020
Q4 		$266K Sell
819
-57
-7% -$15.8K ﹤0.01% 868
2020
Q3 		$243K Sell
876
-1,946
-69% -$561K ﹤0.01% 884
2020
Q2 		$682K Buy
+2,822
New +$567K 0.01% 639
2020
Q1 		– Sell
-1,354
Closed -$231K – 850
2019
Q4 		$231K Buy
+1,354
New +$251K ﹤0.01% 822
2018
Q3 		– Sell
-1,987
Closed -$813K – 750
2018
Q2 		$813K Buy
+1,987
New +$720K 0.01% 495

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Rafferty Asset Management's ABMD Position: Q4 2022 in Review

Rafferty Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 4,406 shares — an estimated $1.08M sold.

Rafferty Asset Management first reported a position in ABMD in Q2 2018 and held it in 12 quarters. The position peaked at $1.08M in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Rafferty Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Rafferty Asset Management sold 4,406 Abiomed Inc shares in Q4 2022, an estimated $1.08M.
  • Rafferty Asset Management first reported a position in Abiomed Inc in Q2 2018 and held it in 12 quarters.
  • Rafferty Asset Management's Abiomed Inc position peaked at $1.08M in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Rafferty Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.